Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
EMMESSA.BOthis companyEmmessar Biotech & Nutrition Limited	₹23.98	29.09×	1.56×	34.19×	-3.96×	-56.4%	-241.7%	-392.0%	117.6%	5.4%	-12.0%	5.1%	0×	5.41×	-581.48×	20.27×	0.0%	3	—	3	B-
BERLDRG.BOBeryl Drugs Limited	₹25.49	22.95×	0.99×	0.5×	4.91×	-329.6%	28.6%	4.8%	2.2%	4.3%	5.2%	-5.3%	0.25×	0.89×	2.71×	1.52×	0.0%	5	3.87	1	C-
COLINZ.BOColinz Laboratories Limited	₹70.00	21.81×	1.12×	1.83×	7.57×	-17.6%	25.6%	4.1%	8.4%	5.1%	1.8%	28.8%	0.04×	-19.97×	5.39×	3.93×	0.0%	4	7.16	5	S-
DESHRAK.BODesh Rakshak Aushdhalaya Ltd.	₹24.50	27.55×	1.17×	2.19×	13.04×	-60.8%	58.0%	13.4%	7.9%	4.2%	4.8%	-18.0%	0.21×	1.9×	3.34×	2.49×	0.0%	5	1.74	1	D+
EVOQ.BOEvoq Remedies Ltd.	₹1.60	-25.2×	0.14×	0.24×	-30.58×	-7336.2%	0.1%	-5.9%	-0.9%	-0.5%	-3.2%	-4.7%	0×	-0.34×	0×	6.77×	0.0%	3	1.82	2	B-
NORRIS.BONorris Medicines Limited	₹14.25	-47.32×	-0.88×	1.63×	48.99×	-220.4%	47.1%	26.5%	-3.5%	1.9%	33.8%	4.3%	-1.42×	30.29×	0×	0.61×	0.0%	2	—	1	D+
Peer median	—	21.81×	0.99×	1.63×	7.57×	-220.4%	28.6%	4.8%	2.2%	4.2%	4.8%	-4.7%	0.04×	0.89×	2.71×	2.49×	0.0%	4	2.85	1	—